The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Methods in health service research: An introduction to bayesian methods in health technology assessment
Open accessAbstract
This is the third of four articles Bayes's theorem arose from a posthumous publication in 1763 by Thomas Bayes, a non-conformist minister from Tunbridge Wells. Although it gives a simple and uncontroversial result in probability theory, specific uses of the theorem have been the subject of considerable controversy for more than two centuries. In recent years a more balanced and pragmatic perspective has emerged, and in this paper we review current thinking on the value of the Bayesian approach to health technology assessment. A concise definition of bayesian methods in health technology assessment has not been established, but we suggest the following: the explicit quantitative use of external evidence in the design, monitoring, analysis, interpretation, and reporting of a health technology assessment. This approach acknowledges that judgments about the benefits of a new technology will rarely be based solely on the results of a single study but should synthesise evidence from multiple sources—for example, pilot studies, trials of similar interventions, and even subjective judgments about the generalisability of the study's results. A bayesian perspective leads to an approach to clinical trials that is claimed to be more flexible and ethical than traditional methods,1 and to elegant ways of handling multiple substudies—for example, when simultaneously estimating the effects of a treatment on many subgroups.2 Proponents have also argued that a bayesian approach allows conclusions to be provided in a form that is most suitable for decisions specific to patients and decisions affecting public policy.3 #### Summary points Bayesian methods interpret data from a study in the light of external evidence and judgment, and the form in which conclusions are drawn contributes naturally to decision making Prior plausibility of hypotheses is taken into account, just as when interpreting the results of a diagnostic test Scepticism about large treatment effects can be formally …
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(1996) · Cited by 6,884
Clinical Epidemiology: A Basic Science for Clinical Medicine.
(1991) · Annals of Internal Medicine · doi:10.7326/0003-4819-114-9-825_9 · Cited by 3,476
Estimates of the worldwide incidence of 25 major cancers in 1990
Parkin, Pisani, P., & Ferlay, J. (1999) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19990315)80:6<827::aid-ijc6>3.0.co;2-p · Cited by 2,037
Bayesian approaches to randomized trials
Spiegelhalter, D. J., Freedman, L. S., & Parmar, M. K. B. (1994) · Journal of the Royal Statistical Society. Series A (Statistics in Society) · doi:10.2307/2983527 · Cited by 720
Self-citationStatistical Principles for Clinical Trials
Kay, R. (1998) · Journal of International Medical Research · doi:10.1177/030006059802600201 · Cited by 573
Cancer and infection: estimates of the attributable fraction in 1990.
Pisani, P., Parkin, D. M., Muñóz, N., & Ferlay, J. (1997) · PubMed · Cited by 448
META-ANALYSIS IN THE DESIGN AND MONITORING OF CLINICAL TRIALS
DERSIMONIAN, R. (1996) · Statistics in Medicine · doi:10.1002/(sici)1097-0258(19960630)15:12<1237::aid-sim301>3.0.co;2-n · Cited by 257
Peto, R., & Baigent, C. (1998) · BMJ · doi:10.1136/bmj.317.7167.1170 · Cited by 243
For Debate: The statistical basis of public policy: a paradigm shift is overdue
Lilford, R. J., & Braunholtz, D. (1996) · BMJ · doi:10.1136/bmj.313.7057.603 · Cited by 188
MeWAnalysis by the Confidence Profile Method: The Statistical Synthesis of Evidence
Lenth, R. V., Eddy, D. M., Hasselblad, V., & Shachter, R. (1993) · Technometrics · doi:10.1080/00401706.1993.10485067 · Cited by 148
Human papillomavirus in a necessary cause of invasive cervical cancer worldwide
(1999) · Pure Amsterdam UMC · doi:10.1002/(sici)1096-9896(199909)189:1 · Cited by 140
Smith, J. M. (1999) · Nature · doi:10.1038/22238 · Cited by 133
TUTORIAL IN BIOSTATISTICS: BAYESIAN DATA MONITORING IN CLINICAL TRIALS
Fayers, P. M., Ashby, D., & Parmar, M. (1997) · Statistics in Medicine · doi:10.1002/(sici)1097-0258(19970630)16:12<1413::aid-sim578>3.0.co;2-u · Cited by 128
The chart trials: Bayesian design and monitoring in practice
Parmar, M., Spiegelhalter, D. J., & Freedman, L. S. (1994) · Statistics in Medicine · doi:10.1002/sim.4780131304 · Cited by 112
Self-citationThe what, why and how of bayesian clinical trials monitoring
Freedman, L. S., Spiegelhalter, D. J., & Parmar, M. (1994) · Statistics in Medicine · doi:10.1002/sim.4780131312 · Cited by 108
Self-citationGraphical Elicitation of a Prior Distribution for a Clinical Trial
Chaloner, K. M., Church, T. R., Louis, T. A., & Matts, J. P. (1993) · Journal of the Royal Statistical Society Series D (The Statistician) · doi:10.2307/2348469 · Cited by 106
An Introduction to a Bayesian Method for Meta-analysis: The Confidence Profile Method
Eddy, D. M., Hasselblad, V., & Shachter, R. D. (1990) · Medical Decision Making · doi:10.1177/0272989x9001000104 · Cited by 101
RECENT METHODOLOGICAL CONTRIBUTIONS TO CLINICAL TRIALS
Cornfield, J. (1976) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a112313 · Cited by 101
Breslow, N. E. (1990) · Statistical Science · doi:10.1214/ss/1177012092 · Cited by 98
Kadane, J. B. (1995) · Controlled Clinical Trials · doi:10.1016/0197-2456(95)00072-0 · Cited by 65
An introduction to the Bayesian analysis of clinical trials
Lewis, R., & Wears, R. L. (1993) · Annals of Emergency Medicine · doi:10.1016/s0196-0644(05)80119-2 · Cited by 64
Bayesian subset analysis in a colorectal cancer clinical trial
Dixon, D. O., & Simon, R. M. (1992) · Statistics in Medicine · doi:10.1002/sim.4780110104 · Cited by 61
Assessing Whether to Perform a Confirmatory Randomized Clinical Trial
Parmar, M., Ungerleider, R. S., & Simon, R. (1996) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/88.22.1645 · Cited by 59
Using empirical bayes methods in biopharmaceutical research
Louis, T. A. (1991) · Statistics in Medicine · doi:10.1002/sim.4780100604 · Cited by 58
A unified method for monitoring and analysing controlled trials
Grossman, J., Parmar, M., Spiegelhalter, D. J., & Freedman, L. S. (1994) · Statistics in Medicine · doi:10.1002/sim.4780131804 · Cited by 35
Self-citationDecision making during a Phase III randomized controlled trial
Berry, D. A. (1994) · Controlled Clinical Trials · doi:10.1016/0197-2456(94)90033-7 · Cited by 34
Domiciliary thrombolysis by general practitioners.
Pocock, S., & Spiegelhalter, D. J. (1992) · BMJ · doi:10.1136/bmj.305.6860.1015 · Cited by 28
Self-citationBayesian data monitoring in clinical trials
Fayers, P. M., Ashby, D., & Parmar, M. (1997) · UCL Discovery (University College London) · Cited by 21
Meta-analysis and the synthesis of evidence
Abrams, K. R., & Jones, D. R. H. (1995) · Mathematical Medicine and Biology A Journal of the IMA · doi:10.1093/imammb/12.3-4.297 · Cited by 17
Self-citation
Cited by
Systematic reviews in the social sciences: a practical guide
(2006) · Choice Reviews Online · doi:10.5860/choice.43-5664 · Cited by 4,089
Guidance on Conducting a Systematic Literature Review
Xiao, Y., & Watson, M. (2019) · Journal of Planning Education and Research · doi:10.1177/0739456x17723971 · Cited by 3,467
Simultaneous comparison of multiple treatments: Combining direct and indirect evidence.
Caldwell, D. M., Ades, A. E., & Higgins, J. P. T. (2005) · BMJ · doi:10.1136/bmj.331.7521.897 · Cited by 1,600
Brok, J., Thorlund, K., Wetterslev, J., & Gluud, C. (2009) · International Journal of Epidemiology · doi:10.1093/ije/dyn188 · Cited by 917
Bayesian methods in meta-analysis and evidence synthesis
Sutton, A. J., & Abrams, K. R. (2001) · Statistical Methods in Medical Research · doi:10.1177/096228020101000404 · Cited by 710
Self-citation
Metadata
- Authors
- Spiegelhalter, D. J., Myles, J. P., Jones, D. R., & Abrams, K. R.
- Venue
- BMJ
- Publisher
- BMJ
- Published
- 1999-08-21
- Volume
- 319
- Issue
- 7208
- Pages
- 508-512
- ISSN
- 0007-1447 (ISSN-L)
- 0959-8138
- 1468-5833
- OpenAlex
- W2093243674
- Cited by
- 421
- References
- 30
- FWCI
- 15.91
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.